Prostate Cancer Test Predicts Radiotherapy Benefits After Radical Prostatectomy

Prostate Cancer Test Predicts Radiotherapy Benefits After Radical Prostatectomy
GenomeDx Biosciences recently announced the publication of a positive validation study for its Decipher Prostate Cancer Classifier, a genomic test for men with intermediate and high-risk prostate cancer. In the study titled “A Genomic Classifier Identifies Men with Adverse Pathology after Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy,” published in the Journal of Clinical Oncology,” researchers from

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , .

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

Leave a Comment

Your email address will not be published. Required fields are marked *